ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682237; 2) Community: the network communities that were significantly associated with the response to NSC 682237; 3) Molecule: the relationships between components within communities and NSC 682237; 4) MDR: the compounds that were significantly associated with the NSC 682237.

NSC Compound Enrichment Correlation
NSC 717859 Null 0.00306027196853062 -0.23659306
NSC 732937 6-(3-Azidopropyl)-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-i ndeno[1,2-c]isoquinoline 0.00306027196853062 0.2001023
NSC 689140 1H,3H-Benzo[c]pyrrolo[3,4-a]carbazole-1,3-dione, 2,3a,3b,4,5,6,7,7a-octahydro-2-(4-methoxyphenyl)- 9-methyl-5-phenyl- 0.00347157511980527 0.44074447
NSC 295501 Camptothecin Derivative 0.00347157511980532 0.32829575
NSC 348894 Benzenesulfonamide, 4-[(9-acridinylmethyl)amino]-N-(aminoiminomethyl)- 0.00347157511980532 0.37248344
NSC 58575 Pyrimidine, 2,4,5-trichloro-6-isopropyl- 0.00347157511980532 0.097848946
NSC 654895 Null 0.00347157511980532 0.15245233
NSC 357704 Cyanomorpholinodoxorubicin 0.00404192617431249 0.28108852
NSC 658103 Null 0.00404192617431249 0.27803779
NSC 681636 Camptothecin Derivative 0.00404192617431249 0.26150407
Total:42  Current:4    [First] [Prev] [Next] [Last]